Nama, S., Muhuri, M., Di Pascale, F., Quah, S., Aswad, L., Fullwood, M., . . . Sciences, S. o. B. (2020). MicroRNA-138 is a prognostic biomarker for triple-negative breast cancer and promotes tumorigenesis via TUSC2 repression.
Chicago Style CitationNama, Srikanth, Manish Muhuri, Federica Di Pascale, Shan Quah, Luay Aswad, Melissa Fullwood, Prabha Sampath, and School of Biological Sciences. MicroRNA-138 Is a Prognostic Biomarker for Triple-negative Breast Cancer and Promotes Tumorigenesis Via TUSC2 Repression. 2020.
MLA CitationNama, Srikanth, et al. MicroRNA-138 Is a Prognostic Biomarker for Triple-negative Breast Cancer and Promotes Tumorigenesis Via TUSC2 Repression. 2020.
Warning: These citations may not always be 100% accurate.